ES458688A1 - Procedimiento de preparacion de nuevos derivados del ditiol-1,2. - Google Patents

Procedimiento de preparacion de nuevos derivados del ditiol-1,2.

Info

Publication number
ES458688A1
ES458688A1 ES458688A ES458688A ES458688A1 ES 458688 A1 ES458688 A1 ES 458688A1 ES 458688 A ES458688 A ES 458688A ES 458688 A ES458688 A ES 458688A ES 458688 A1 ES458688 A1 ES 458688A1
Authority
ES
Spain
Prior art keywords
carbon atoms
alkyl
whose
radical containing
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES458688A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc Industries SA
Original Assignee
Rhone Poulenc Industries SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7603604A external-priority patent/FR2340730A1/fr
Priority claimed from FR7638901A external-priority patent/FR2374906A2/fr
Application filed by Rhone Poulenc Industries SA filed Critical Rhone Poulenc Industries SA
Publication of ES458688A1 publication Critical patent/ES458688A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/38—One sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Procedimiento de preparación de nuevos derivados del ditiol-1,2 de fórmula general: *** ver imagen 01 en la que Het representa un radical heterocíclico aromático de 6 anillos que contiene 2 átomos de nitrógeno, eventualmente sustituido por un átomo de halógeno o por un radical alquilo que contiene 1 a 4 átomos de carbono, alquiloxilo cuya parte alquilo contiene 1 a 4 átomos de carbono, mercapto, alquiltio cuya parte alquilo contiene 1 a 4 átomos de carbono, y R representa un radical carbamoilo en N-alquilcarbamoilo cuya parte alquilo contiene 1 a 4 átomos de carbono.
ES458688A 1976-02-10 1977-05-11 Procedimiento de preparacion de nuevos derivados del ditiol-1,2. Expired ES458688A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7603604A FR2340730A1 (fr) 1976-02-10 1976-02-10 Nouveaux derives du dithiole-1,2, leur preparation et les compositions qui les contiennent
FR7638901A FR2374906A2 (fr) 1976-12-23 1976-12-23 Nouveaux derives du dithiole-1,2, leur preparation et les compositions qui les contiennent

Publications (1)

Publication Number Publication Date
ES458688A1 true ES458688A1 (es) 1978-07-16

Family

ID=26219294

Family Applications (3)

Application Number Title Priority Date Filing Date
ES455790A Expired ES455790A1 (es) 1976-02-10 1977-02-10 Procedimiento de preparacion de nuevos derivados del di- tiol-1,2.
ES458689A Expired ES458689A1 (es) 1976-02-10 1977-05-11 Procedimiento de preparacion de nuevos derivados del ditiol-1,2.
ES458688A Expired ES458688A1 (es) 1976-02-10 1977-05-11 Procedimiento de preparacion de nuevos derivados del ditiol-1,2.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES455790A Expired ES455790A1 (es) 1976-02-10 1977-02-10 Procedimiento de preparacion de nuevos derivados del di- tiol-1,2.
ES458689A Expired ES458689A1 (es) 1976-02-10 1977-05-11 Procedimiento de preparacion de nuevos derivados del ditiol-1,2.

Country Status (26)

Country Link
US (1) US4110450A (es)
JP (1) JPS5822119B2 (es)
AR (1) AR224095A1 (es)
AT (1) AT348535B (es)
AU (1) AU509092B2 (es)
CA (1) CA1073906A (es)
CH (2) CH618699A5 (es)
DE (1) DE2705641C3 (es)
DK (1) DK55477A (es)
EG (1) EG13739A (es)
ES (3) ES455790A1 (es)
GB (1) GB1518071A (es)
HK (1) HK17481A (es)
HU (1) HU172528B (es)
IE (1) IE44561B1 (es)
IL (1) IL51403A (es)
KE (1) KE3126A (es)
LU (1) LU76728A1 (es)
MY (1) MY8200001A (es)
NL (1) NL171985C (es)
OA (1) OA05565A (es)
PH (1) PH12367A (es)
PT (1) PT66175B (es)
SE (1) SE427274B (es)
SU (1) SU683622A3 (es)
ZM (1) ZM1477A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001125A (en) 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
WO1999021834A1 (en) * 1997-10-27 1999-05-06 Neurosearch A/S Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
AU2001259484A1 (en) 2000-05-05 2001-11-20 Wisconsin Alumni Research Foundation Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy
KR100491318B1 (ko) * 2002-11-26 2005-05-24 씨제이 주식회사 올티프라즈(Ｏｌｔｉｐｒａｚ) 제조방법
CN101083982A (zh) 2004-09-20 2007-12-05 泽农医药公司 用于治疗硬脂酰CoA去饱和酶介导的疾病的杂环衍生物
AU2005329423A1 (en) 2004-09-20 2006-09-28 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
TW200626155A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
TW200626154A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
WO2006034279A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as therapeutic agents
BRPI0515478A (pt) 2004-09-20 2008-07-22 Xenon Pharmaceuticals Inc derivados heterocìclicos e seu uso como mediadores de estearoil-coa-desaturase
CN101084207A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其作为硬脂酰CoA去饱和酶抑制剂的用途
BRPI0611187A2 (pt) 2005-06-03 2010-08-24 Xenon Pharmaceuticals Inc derivados aminotiazàis como inibidores da estearoil-coa desaturase humana
US7910600B2 (en) * 2007-08-31 2011-03-22 Cylene Pharmaceuticals, Inc. Therapeutic kinase modulators
US20160376259A1 (en) 2015-06-25 2016-12-29 St Ip Holding Ag Methods for Preparing Oltipraz
WO2016207914A2 (en) * 2015-06-25 2016-12-29 St Ip Holding Ag Methods for preparing oltipraz
WO2018047002A1 (en) 2016-09-12 2018-03-15 St Ip Holding Ag Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1.2-dithiole-3-thione, taste-modified formulations, and methods of making and using same
WO2018047013A1 (en) 2016-09-12 2018-03-15 St Ip Holding Ag Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1, 2-dithiole-3-thione, and methods of making and using same
EP3762104A2 (en) 2018-03-07 2021-01-13 ST IP Holding AG Combination compositions and therapies comprising 4-methyl-5-(pyrazin-2-yl)-3h-1,2-dithiole-3-thione, and methods of making and using same
US11135220B1 (en) 2020-04-08 2021-10-05 St Ip Holding Ag Methods of treating viral infections with formulated compositions comprising 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1526768A (fr) 1963-01-16 1968-05-31 Procédé de préparation de dérivés sulfoniques de dithiole-1, 2 thiones-3 diversement substituées, et applications des produits ainsi obtenus

Also Published As

Publication number Publication date
AR224095A1 (es) 1981-10-30
CA1073906A (fr) 1980-03-18
NL7701107A (nl) 1977-08-12
ES458689A1 (es) 1978-07-16
IL51403A0 (en) 1977-04-29
US4110450A (en) 1978-08-29
DK55477A (da) 1977-08-11
IL51403A (en) 1980-09-16
CH619463A5 (es) 1980-09-30
JPS5822119B2 (ja) 1983-05-06
PT66175B (fr) 1978-07-10
AU509092B2 (en) 1980-04-17
DE2705641B2 (de) 1980-05-08
KE3126A (en) 1981-05-29
SU683622A3 (ru) 1979-08-30
DE2705641A1 (de) 1977-08-11
SE427274B (sv) 1983-03-21
ZM1477A1 (en) 1977-12-21
HK17481A (en) 1981-05-08
MY8200001A (en) 1982-12-31
HU172528B (hu) 1978-09-28
PH12367A (en) 1979-01-29
PT66175A (fr) 1977-03-01
EG13739A (en) 1983-03-31
AT348535B (de) 1979-02-26
ATA90277A (de) 1978-07-15
OA05565A (fr) 1981-04-30
SE7701460L (sv) 1977-08-11
IE44561B1 (en) 1982-01-13
IE44561L (en) 1977-08-10
DE2705641C3 (de) 1981-01-22
LU76728A1 (es) 1977-08-18
GB1518071A (en) 1978-07-19
NL171985C (nl) 1983-06-16
ES455790A1 (es) 1978-01-16
CH618699A5 (es) 1980-08-15
AU2213877A (en) 1978-08-17
JPS52113982A (en) 1977-09-24

Similar Documents

Publication Publication Date Title
ES458688A1 (es) Procedimiento de preparacion de nuevos derivados del ditiol-1,2.
PH12622A (en) Derivatives of 1,2-dithiole
ES462305A1 (es) Un procedimiento para la preparacion de nuevos derivados de urazol 1,2,4-sustituidos.
ES454823A1 (es) Procedimiento para la preparacion de derivados de imidazo (1,2-a) piridina.
JPS5430183A (en) 3,4-dihydrocarbostyril derivative
ES395766A1 (es) Procedimiento para la obtencion de derivados de la hidan- toina.
ES440438A1 (es) Procedimiento para la preparacion de nuevos derivados de fe-nilbutazona.
ES458687A1 (es) Procedimiento de preparacion de nuevos derivado del ditiol -1,2.
ES460297A1 (es) Un compuesto.
ES474461A1 (es) Procedimiento de obtencion de amidas desoxivincaminicas.
ES451655A1 (es) Un procedimiento para la preparacion de derivados de pirimi-dina.
ES462441A1 (es) Un procedimiento para la preparacion de imidazoles.
ES451741A2 (es) Procedimiento para preparar derivados de naftiridina.
ES445922A1 (es) Procedimiento para preparar derivados de benzofuranona.
ES469579A1 (es) Procedimiento para la preparacion de 5-(indol-3-ilmetilen)- 1,3-dimetil-2 - metilimino-4 - imidazolidinona opcionalmente6-alquil sustituida.
ES455538A1 (es) Un procedimiento para la preparacion de nuevos derivados de piperidina.
ES482948A1 (es) Un procedimiento para la preparacion de derivados de oxadia-zolotriazona
ES455592A1 (es) Procedimiento para la preparacion de hidrazinas.
ES463284A2 (es) Procedimiento para preparar 1-(3,3,3-triarilpropil)-4-fenil-4-piperidina-metanoles.
ES8304119A1 (es) "procedimiento para la obtencion de n-(2-oxo-1-pirrolidinil)acetil piperazinas sustituidas".
ES462369A3 (es) Un procedimiento de preparacion de un derivado de 7 alfa-me-toxicefalosporina con un sustituyente 7 beta.
ES460745A3 (es) Procedimiento para la obtencion de sulfoxidos y sulfonas de-rivados del tiocarbonato de accion herbicida.
ES461256A1 (es) Un procedimiento para preparar derivados de 1,4-dihidropiri-dina.
ES479266A1 (es) Procedimiento de obtencion de derivados del acido (3,2-c)- pirazolo oleanolico esterificados.
ES456351A1 (es) Procedimiento para preparar esteres o,s-dialquil-o-pirazoli-cos de acido ditiofosforico.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990601